Cargando…

Therapy of Subclinical Mastitis during Lactation

This study tested the hypothesis that increasing the duration and/or frequency of antimicrobial treatment of subclinical mastitis would result in a higher bacteriological cure rate. Glands with a positive California mastitis test (CMT) from cows with an elevated somatic cell count (>500,000 cells...

Descripción completa

Detalles Bibliográficos
Autores principales: McDougall, Scott, Clausen, Laura M., Hussein, Hassan M., Compton, Chris W. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868077/
https://www.ncbi.nlm.nih.gov/pubmed/35203812
http://dx.doi.org/10.3390/antibiotics11020209
_version_ 1784656177846550528
author McDougall, Scott
Clausen, Laura M.
Hussein, Hassan M.
Compton, Chris W. R.
author_facet McDougall, Scott
Clausen, Laura M.
Hussein, Hassan M.
Compton, Chris W. R.
author_sort McDougall, Scott
collection PubMed
description This study tested the hypothesis that increasing the duration and/or frequency of antimicrobial treatment of subclinical mastitis would result in a higher bacteriological cure rate. Glands with a positive California mastitis test (CMT) from cows with an elevated somatic cell count (>500,000 cells/mL) that had an intramammary infection were randomly assigned at cow level to no treatment (Control; n = 80 glands), intramammary infusion of 200 mg cloxacillin sodium on three occasions at 48 h intervals (3 × 48 h; n = 273 glands), five occasions at 24 h intervals (5 × 24 h; n = 279 glands), or on five occasions at 48 h intervals (5 × 48 h; n = 72 glands). Glands were resampled at 21 (±3) and 28 (±3) days after initiation of treatment. The gland-level cure rate for any pathogen was 5/80 (6.2%), 139/173 (49.8%), 172/297 (61.6%) and 58/72 (80.6%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. The cure rate for major pathogens (defined as Staphylococcus aureus or Streptococcus spp.) was 4/52 (7.7%), 84/197 (42.6%), 96/183 (52.5%) and 36/48 (75%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. We conclude that treatment was superior to no treatment, and bacteriological cure rate was higher with the 5 × 24 h protocol than for the 3 × 48 h protocol and was higher with the 5 × 48 h than the 5 × 24 h protocol.
format Online
Article
Text
id pubmed-8868077
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88680772022-02-25 Therapy of Subclinical Mastitis during Lactation McDougall, Scott Clausen, Laura M. Hussein, Hassan M. Compton, Chris W. R. Antibiotics (Basel) Article This study tested the hypothesis that increasing the duration and/or frequency of antimicrobial treatment of subclinical mastitis would result in a higher bacteriological cure rate. Glands with a positive California mastitis test (CMT) from cows with an elevated somatic cell count (>500,000 cells/mL) that had an intramammary infection were randomly assigned at cow level to no treatment (Control; n = 80 glands), intramammary infusion of 200 mg cloxacillin sodium on three occasions at 48 h intervals (3 × 48 h; n = 273 glands), five occasions at 24 h intervals (5 × 24 h; n = 279 glands), or on five occasions at 48 h intervals (5 × 48 h; n = 72 glands). Glands were resampled at 21 (±3) and 28 (±3) days after initiation of treatment. The gland-level cure rate for any pathogen was 5/80 (6.2%), 139/173 (49.8%), 172/297 (61.6%) and 58/72 (80.6%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. The cure rate for major pathogens (defined as Staphylococcus aureus or Streptococcus spp.) was 4/52 (7.7%), 84/197 (42.6%), 96/183 (52.5%) and 36/48 (75%) for Control, 3 × 48 h, 5 × 24 h and 5 × 48 h, respectively. We conclude that treatment was superior to no treatment, and bacteriological cure rate was higher with the 5 × 24 h protocol than for the 3 × 48 h protocol and was higher with the 5 × 48 h than the 5 × 24 h protocol. MDPI 2022-02-07 /pmc/articles/PMC8868077/ /pubmed/35203812 http://dx.doi.org/10.3390/antibiotics11020209 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
McDougall, Scott
Clausen, Laura M.
Hussein, Hassan M.
Compton, Chris W. R.
Therapy of Subclinical Mastitis during Lactation
title Therapy of Subclinical Mastitis during Lactation
title_full Therapy of Subclinical Mastitis during Lactation
title_fullStr Therapy of Subclinical Mastitis during Lactation
title_full_unstemmed Therapy of Subclinical Mastitis during Lactation
title_short Therapy of Subclinical Mastitis during Lactation
title_sort therapy of subclinical mastitis during lactation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868077/
https://www.ncbi.nlm.nih.gov/pubmed/35203812
http://dx.doi.org/10.3390/antibiotics11020209
work_keys_str_mv AT mcdougallscott therapyofsubclinicalmastitisduringlactation
AT clausenlauram therapyofsubclinicalmastitisduringlactation
AT husseinhassanm therapyofsubclinicalmastitisduringlactation
AT comptonchriswr therapyofsubclinicalmastitisduringlactation